Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.0B | 9.3B | 9.6B | 9.2B |
Cost of revenue | 6.0B | 6.9B | 5.9B | 6.2B |
Gross profit | 2.9B | 2.4B | 3.7B | 3.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.7B | 1.7B | 2.0B | 1.6B |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 682M | 1.7B | 1.3B |
Non operating interest income | ||||
Income | 98M | — | 93M | 83M |
Expense | 151M | 137M | 127M | 129M |
Other income expense | -266M | — | -297M | -68M |
Pretax income | 855M | 545M | 1.6B | 1.1B |
Tax provision | 230M | 154M | 216M | 326M |
Net income | 644M | 407M | 1.7B | 856M |
Basic EPS | 0.5 | 0.3 | 1.3 | 0.6 |
Diluted EPS | 0.5 | 0.3 | 1.3 | 0.6 |
Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
Diluted average shares | 1.3B | 1.3B | 1.3B | 1.3B |
EBITDA | 1.3B | 1.0B | 2.1B | 1.8B |
Net income from continuing op. | 644M | 407M | 1.7B | 856M |
Minority interests | -3M | -5M | -3M | -3M |
Preferred stock dividends | — | — | — | — |